Werbung
Werbung
FLGT
Fulgent Genetics, Inc. Common Stock
27.86
USDGesponsert
-0.03
-0.09%
09. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
27.71
-0.15
-0.54%
FLGT Ergebnisberichte
Positives Überraschungsverhältnis
FLGT übertreffen die 28 der letzten 37Schätzungen.
76%
Nächster Bericht
Datum des nächsten Berichts
26. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$87.09M
/$0.03
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+3.59%
/-78.57%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+14.27%
/-25.00%
Fulgent Genetics, Inc. Common Stock earnings per share and revenue
On 07. Nov. 2025, FLGT reported earnings of 0.14 USD per share (EPS) for Q3 25, beating the estimate of -0.22 USD, resulting in a 161.46% surprise. Revenue reached 84.07 million, compared to an expected 83.06 million, with a 1.22% difference. The market reacted with a +18.15% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 87.09 million USD, implying an decrease of -78.57% EPS, and increase of 3.59% in Revenue from the last quarter.
FAQ
What were Fulgent Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fulgent Genetics, Inc. Common Stock reported EPS of $0.14, beating estimates by 161.46%, and revenue of $84.07M, 1.22% above expectations.
How did the market react to Fulgent Genetics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 18.15%, changed from $22.31 before the earnings release to $26.36 the day after.
When is Fulgent Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26. Feb. 2026.
What are the forecasts for Fulgent Genetics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Fulgent Genetics, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $87.09M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung